KR20160147136A - A composition for skin whitening or regeneration comprising Melandrium firmum extract - Google Patents
A composition for skin whitening or regeneration comprising Melandrium firmum extract Download PDFInfo
- Publication number
- KR20160147136A KR20160147136A KR1020150082862A KR20150082862A KR20160147136A KR 20160147136 A KR20160147136 A KR 20160147136A KR 1020150082862 A KR1020150082862 A KR 1020150082862A KR 20150082862 A KR20150082862 A KR 20150082862A KR 20160147136 A KR20160147136 A KR 20160147136A
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- extract
- skin
- present
- skin whitening
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 88
- 239000000284 extract Substances 0.000 title claims abstract description 66
- 230000002087 whitening effect Effects 0.000 title claims abstract description 35
- 241001335355 Silene firma Species 0.000 title claims abstract description 8
- 230000008929 regeneration Effects 0.000 title abstract description 9
- 238000011069 regeneration method Methods 0.000 title abstract description 9
- 239000002537 cosmetic Substances 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 21
- 239000004480 active ingredient Substances 0.000 claims abstract description 19
- 230000004663 cell proliferation Effects 0.000 claims abstract description 12
- 229940079593 drug Drugs 0.000 claims abstract description 8
- 239000003814 drug Substances 0.000 claims abstract description 8
- 230000001737 promoting effect Effects 0.000 claims abstract description 5
- 230000036560 skin regeneration Effects 0.000 claims abstract description 5
- 230000001172 regenerating effect Effects 0.000 claims description 19
- 238000009472 formulation Methods 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 230000008099 melanin synthesis Effects 0.000 claims description 13
- 235000013376 functional food Nutrition 0.000 claims description 11
- 230000036541 health Effects 0.000 claims description 11
- 239000000839 emulsion Substances 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 9
- 239000000725 suspension Substances 0.000 claims description 8
- 230000007760 free radical scavenging Effects 0.000 claims description 7
- 230000002401 inhibitory effect Effects 0.000 claims description 7
- 239000006210 lotion Substances 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 239000000344 soap Substances 0.000 claims description 5
- 244000299461 Theobroma cacao Species 0.000 claims description 4
- 235000009508 confectionery Nutrition 0.000 claims description 4
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 235000019634 flavors Nutrition 0.000 claims description 4
- 239000003921 oil Substances 0.000 claims description 4
- 239000002674 ointment Substances 0.000 claims description 4
- 239000004094 surface-active agent Substances 0.000 claims description 4
- 235000019219 chocolate Nutrition 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 3
- 239000000499 gel Substances 0.000 claims description 3
- 239000006072 paste Substances 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 235000008429 bread Nutrition 0.000 claims description 2
- 239000006260 foam Substances 0.000 claims description 2
- 235000015243 ice cream Nutrition 0.000 claims description 2
- 235000013372 meat Nutrition 0.000 claims description 2
- 235000016709 nutrition Nutrition 0.000 claims description 2
- 235000013550 pizza Nutrition 0.000 claims description 2
- 235000013580 sausages Nutrition 0.000 claims description 2
- 235000011888 snacks Nutrition 0.000 claims description 2
- 235000014347 soups Nutrition 0.000 claims description 2
- 238000006253 efflorescence Methods 0.000 claims 1
- 239000004816 latex Substances 0.000 claims 1
- 229920000126 latex Polymers 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 31
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 9
- 230000019612 pigmentation Effects 0.000 abstract description 8
- 230000001629 suppression Effects 0.000 abstract description 2
- 235000013402 health food Nutrition 0.000 abstract 1
- 230000003061 melanogenesis Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 56
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 48
- 238000002360 preparation method Methods 0.000 description 22
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 20
- 241000286209 Phasianidae Species 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 238000004519 manufacturing process Methods 0.000 description 13
- -1 rocaborn Substances 0.000 description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 9
- 208000012641 Pigmentation disease Diseases 0.000 description 9
- 102000003425 Tyrosinase Human genes 0.000 description 9
- 108060008724 Tyrosinase Proteins 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 9
- 238000002835 absorbance Methods 0.000 description 8
- 229960005070 ascorbic acid Drugs 0.000 description 8
- 150000003254 radicals Chemical class 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 235000010323 ascorbic acid Nutrition 0.000 description 7
- 239000011668 ascorbic acid Substances 0.000 description 7
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 239000013642 negative control Substances 0.000 description 7
- 239000000049 pigment Substances 0.000 description 7
- 229960000271 arbutin Drugs 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- 235000013373 food additive Nutrition 0.000 description 5
- 239000002778 food additive Substances 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 206010014970 Ephelides Diseases 0.000 description 4
- 241000233866 Fungi Species 0.000 description 4
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 4
- 208000003351 Melanosis Diseases 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000008021 deposition Effects 0.000 description 4
- 239000003599 detergent Substances 0.000 description 4
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 239000012091 fetal bovine serum Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 description 4
- 239000008158 vegetable oil Substances 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000002752 melanocyte Anatomy 0.000 description 3
- 201000001441 melanoma Diseases 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000001953 sensory effect Effects 0.000 description 3
- 210000004927 skin cell Anatomy 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 241001504639 Alcedo atthis Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 229940123457 Free radical scavenger Drugs 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 102100031413 L-dopachrome tautomerase Human genes 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003183 carcinogenic agent Substances 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 108010051081 dopachrome isomerase Proteins 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 229960004337 hydroquinone Drugs 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000007911 parenteral administration Methods 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- WCBPJVKVIMMEQC-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 WCBPJVKVIMMEQC-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- WHNCXIBKVUPNHR-UHFFFAOYSA-N 3,4-dihydroxy-1h-indole-2-carboxylic acid Chemical compound C1=CC(O)=C2C(O)=C(C(=O)O)NC2=C1 WHNCXIBKVUPNHR-UHFFFAOYSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 240000003421 Dianthus chinensis Species 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 208000001382 Experimental Melanoma Diseases 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical group OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 208000009097 Milk Sickness Diseases 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 241000534010 Silene aprica Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- SUSRLLXAXAIZPH-OBPIAQAESA-N hydroquinone beta-D-glucopyranoside Natural products OC[C@H]1O[C@@H](Cc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O SUSRLLXAXAIZPH-OBPIAQAESA-N 0.000 description 1
- 125000000687 hydroquinonyl group Chemical group C1(O)=C(C=C(O)C=C1)* 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- FXURFKFOPCZEKG-UHFFFAOYSA-N indole-5,6-quinone-2-carboxylic acid Chemical compound O=C1C(=O)C=C2NC(C(=O)O)=CC2=C1 FXURFKFOPCZEKG-UHFFFAOYSA-N 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000008101 melanin synthesis pathway Effects 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 231100000332 physical toxicant Toxicity 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000004694 pigment cell Anatomy 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 238000004161 plant tissue culture Methods 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Birds (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 왕불유행 추출물을 포함하는 피부 미백 또는 재생용 조성물 및 이를 이용한 방법에 관한 것이다.
The present invention relates to a skin whitening or regenerating composition containing a quail extract and a method using the same.
피부는 외부환경에 대한 방어벽 역할을 하여 화학물질이나 자외선을 포함한 외부 환경오염 물질 또는 미생물의 침입을 방어함으로써 주위환경으로부터 생체를 보호한다.
The skin acts as a barrier against the external environment and protects the living environment from the surrounding environment by protecting against the entry of foreign pollutants or microorganisms including chemicals and ultraviolet rays.
사람의 피부색은 멜라닌, 카로틴, 헤모글로빈의 양에 따라 결정되며, 그 중에서도 멜라닌이 가장 결정적인 요소로 작용한다. 검은 색소와 단백질의 복합체 형태를 갖는 페놀계 고분자 물질인 멜라닌 색소는 자외선 차단의 역할을 수행한다. 따라서, 멜라닌 색소가 부족한 사람은 햇빛에 매우 민감하여 화상을 입기 쉬우며, 피부암의 발생 확률이 높아지게 된다. 단파장의 자외선 및 발암물질은 피부에서 유해한 자유라디칼을 형성하는데, 멜라닌은 이러한 자유라디칼 등을 제거하여 단백질과 유전자를 보호해 주는 유용한 역할을 한다. 따라서, 멜라닌의 양이 많다는 것은 물리적 또는 화학적 독성 물질로부터 피부를 보호할 수 있는 효과적인 대응 체계를 가지고 있다는 것을 의미한다. The skin color of a person is determined by the amount of melanin, carotene, and hemoglobin, and melanin is the most important factor. The melanin pigment, a phenolic high molecular substance with a complex form of black pigment and protein, acts as a UV barrier. Therefore, a person who lacks the melanin pigment is very sensitive to sunlight, so that it is prone to burn, and the probability of skin cancer is increased. Ultraviolet rays and carcinogens of short wavelengths form harmful free radicals in the skin. Melanin plays a useful role in protecting proteins and genes by removing such free radicals. Thus, a high amount of melanin means that it has an effective countermeasure to protect the skin from physical or chemical toxicants.
멜라닌은 색소 세포 내에 존재하는 티로시나아제(tyrosinase)의 작용에 의해 티로신으로부터 복잡한 과정을 거쳐 생성된다. 생성된 멜라닌은 피부 세포에 전달되고, 표피 박리와 함께 멜라닌이 상실되어 소멸되는 순환 작용을 보인다. 즉, 피부가 자외선에 노출되면 티로시나아제가 활성화되는데, 상기 티로시나아제가 피부조직에 존재하는 티로신에 작용하여 도파(DOPA) 및 도파퀴논을 생성시키는 산화 과정을 유도하고, 이로 인해 피부 색소 세포인 멜라노사이트 내의 멜라노좀에서 멜라닌이 합성되며, 합성된 멜라닌은 피부의 각질 형성 세포인 케라티노사이트로 전달되고, 각질화 과정에 의해 피부 표면에 도달하여 자외선으로부터 피부를 보호하게 된다. 그러나, 멜라닌이 국소적으로 과도하게 합성되거나, 피부 병변 및 노화에 따라 피부의 생리 기능이 떨어지게 되면, 멜라닌이 피부 표면에 침착되어 기미, 주근깨 등의 다양한 색소 침착을 유발하게 된다.
Melanin is produced by a complex process from tyrosine by the action of tyrosinase present in the pigment cells. The resulting melanin is transferred to the skin cells, and melanin is lost with epidermal detachment, and the circulating action appears to disappear. That is, when the skin is exposed to ultraviolet rays, tyrosinase is activated. The tyrosinase activates tyrosine present in the skin tissue to induce an oxidation process of producing dopa (DOPA) and dopaquinone, Melanin is synthesized from melanomas in melanocytes. The synthesized melanin is transferred to keratinocytes, the keratinocytes of the skin, and reaches the skin surface by the keratinization process to protect the skin from ultraviolet rays. However, when melanin is overly synthesized locally, or when the skin physiological function is deteriorated due to skin lesions and aging, melanin is deposited on the skin surface and causes various pigmentation such as spots and freckles.
상기에 기재한 바와 같이 피부 색소 침착(흑화)의 원인과 기작이 밝혀지면서, 피부에서의 멜라닌 색소침착 방지는 주로 하기의 네 가지 관점에서 연구되어 왔다:As described above, the cause and mechanism of skin pigmentation (blackening) are revealed, and prevention of melanin pigment deposition in skin has been mainly studied in the following four perspectives:
1) 멜라닌 합성의 주효소인 티로시나아제 활성을 조절하기 위하여 티로시나아제 합성 저해 물질이나 티로시나아제의 기질에 대한 길항물질 개발;1) development of an antagonist against tyrosinase synthesis inhibitor or tyrosinase substrate to regulate tyrosinase activity, the main enzyme of melanin synthesis;
2) 동물의 멜라닌 생합성 장소인 멜라노사이트의 기능을 저하시키기 위해 멜라노사이트에 독성을 나타내는 물질 개발;2) to develop a substance that shows toxicity to melanocytes in order to lower the function of melanocyte site, which is the place of melanin biosynthesis in animals;
3) 멜라닌 합성 경로의 중간 대사물질인 도파(DOPA)의 산화방지를 위해 도파의 환원물질 개발;3) development of dopa reducing materials to prevent the oxidation of dopamine (DOPA), an intermediate metabolite of the melanin synthesis pathway;
4) 멜라닌 생성 기구인 제1효소 티로시나아제, 도파크롬(DOPA chrome)으로부터 DHICA(5-6,디히드록시인돌-2-카복실산)로의 변환을 촉매하는 제2효소 도파크롬 타우토머라아제(DOPA chrome tautomerase), 및 DHICA로부터 인돌-5,6-퀴논-2-카르복실산(indole-5,6-quinone-2-carboxylic acid)으로의 변환을 촉매하는 제3효소의 활성을 동시에 감소시키는 방법 개발.
4) a first enzyme tyrosinase which is a melanin producing mechanism, a second enzyme dopachrome tautomerase which catalyzes the conversion of DOPA chrome to DHICA (5-6, dihydroxyindole-2-carboxylic acid) DOPA chrome tautomerase) and the activity of a third enzyme that catalyzes the conversion of DHICA to indole-5,6-quinone-2-carboxylic acid Method development.
한편, 피부 색소가 침착되는 것을 방지하거나, 또는 개선하기 위해 사용하고 있는 대표적인 물질에는 티로시아나제 효소 활성을 억제하는 물질인 코지산(kojic acid), 알부틴(arbutin), 하이드로퀴논(hydroquinone), 비타민 C(L-ascorbic acid) 및 이들의 유도체 또는 각종 식물 추출물들이 있다. 그러나, 상기 물질들은 처방계 중에서 분해되어 착색되거나, 이취의 발생, 생체 레벨에서의 효능·효과의 불분명 또는 안전성 문제 등으로 그 사용이 제한되고 있는 실정이다. On the other hand, representative materials used for preventing or improving the deposition of skin pigment include kojic acid, arbutin, hydroquinone, hydroquinone, which are substances which inhibit tyrosinase enzyme activity, Vitamin C (L-ascorbic acid) and derivatives thereof or various plant extracts. However, the use of these substances is limited due to the decomposition and coloring in the prescription system, the generation of odor, the uncertainty of the efficacy or effectiveness at the living body level, or the safety problem.
코지산은 티로시나아제의 활성 부위에 존재하는 구리 이온을 흡착시켜 효소활성을 저해하는데, 화장품에 배합 시 불안정성, 피부 부작용 등의 문제들을 야기하고, 최근 동물실험 결과에서 간암을 유발한다고 밝혀져, 화장품 원료로서의 사용이 중지되었다. 비타민 C 및 그 유도체는 산화가 잘되는 불안정성 때문에 화장품 원료로 사용이 어려우며, 하이드로퀴논은 피부에 대한 미백효과는 탁월하지만 알레르기 유발 특성, 멜라닌 생성 세포에 대한 독성, 피부의 영구 탈색화 등 피부에 대한 자극성이 높다. 또한, 최근에는 발암성 물질로 규정되어 각 나라별로 제한적인 농도만 허가하고 있다. 알부틴은 하이드로퀴논에 글루코피라노사이드(glucopyranoside)가 결합된 유도체이며, 하이드로퀴논의 사용 시 나타나는 부작용이 적으면서 인체에 대한 독성이 없고, 멜라닌 색소의 합성을 억제하는 작용이 있어 멜라닌 색소 침착이 증가하는 피부 질환의 치료제로서의 이용 가능성이 제시되었으나, 그 역시 피부 효소에 의해 일부 분해되는 단점이 있다. 따라서, 소량으로도 효능이 우수하며, 부작용이 적은 안전한 대체 미백제의 개발이 시급한 실정이다.
Kojisan inhibits enzymatic activity by adsorbing copper ions present in the active site of tyrosinase, causing problems such as unstability and skin side effects when added to cosmetics, and recent animal tests have shown that it induces liver cancer, Was discontinued. Vitamin C and its derivatives are difficult to use as a raw material for cosmetics because of its good oxidative instability. Hydroquinone has excellent whitening effect on the skin, but it has allergen-inducing properties, toxicity to melanin-producing cells, Is high. In addition, recently, it is prescribed as a carcinogenic substance, and only limited concentration is allowed in each country. Arbutine is a derivative in which glucopyranoside is bound to hydroquinone. It has little side effects when hydroquinone is used, has no toxicity to the human body, inhibits the synthesis of melanin pigment, and increases melanin pigmentation However, it is also disadvantageous in that it is partially decomposed by skin enzymes. Therefore, it is urgent to develop a safe alternative whitening agent which is excellent in efficacy even in a small amount and has few side effects.
이러한 배경하에서, 본 발명자들은 피부의 미백 또는 재생을 개선시키거나, 또는 향상시키는 효과를 가진 물질을 개발하기 위해 예의 노력한 결과, 왕불유행 추출물이 멜라닌 합성을 효과적으로 억제할 뿐 아니라 자유라디칼 소거, 세포증식 촉진에 우수한 효과가 있음을 규명하여, 이를 활용한 피부의 미백 또는 재생용 화장료 조성물을 완성하였다.
Under these circumstances, the present inventors have made intensive efforts to develop a substance having the effect of improving or improving the whitening or regeneration of skin, and as a result, it has been found that the quail extract effectively inhibits melanin synthesis and also inhibits free radical scavenging, And the cosmetic composition for skin whitening or regeneration using the same was completed.
본 발명의 목적은 왕불유행 추출물(Melandrium firmum)을 유효성분으로 포함하는 피부 미백 또는 재생용 조성물을 제공하는 것이다.It is an object of the present invention to provide a method for the production of melanin firmum ) as an active ingredient.
본 발명의 다른 목적은 왕불유행 추출물을 유효성분으로 포함하는 피부 미백 또는 재생용 화장료 조성물을 제공하는 것이다.It is another object of the present invention to provide a skin whitening or regenerating cosmetic composition comprising an extract of royal flush as an active ingredient.
본 발명의 또 다른 목적은 왕불유행 추출물을 유효성분으로 포함하는 피부 미백 또는 재생용 약학적 조성물을 제공하는 것이다.It is still another object of the present invention to provide a skin whitening or regenerating pharmaceutical composition containing an ascorbic acid extract as an active ingredient.
본 발명의 또 다른 목적은 왕불유행 추출물을 유효성분으로 포함하는 피부 미백 또는 재생용 건강기능식품 조성물을 제공하는 것이다.It is another object of the present invention to provide a skin whitening or regenerating health functional food composition comprising an extract of King Fahrenheit as an active ingredient.
본 발명의 또 다른 목적은 왕불유행 추출물을 유효성분으로 포함하는 피부 미백 또는 재생용 의약외품 조성물을 제공하는 것이다.It is another object of the present invention to provide a skin whitening or quasi-quasi-composition for regeneration, which comprises a quail extract as an active ingredient.
본 발명의 또 다른 목적은 왕불유행 추출물을 유효성분으로 포함하는 조성물을 개체에 투여하는 단계를 포함하는 피부 미백 또는 재생 방법을 제공하는 것이다.
Yet another object of the present invention is to provide a skin whitening or regenerating method comprising the step of administering to a subject a composition containing an ascorbic acid extract as an active ingredient.
상기 목적을 해결하기 위한 하나의 양태로서, 본 발명은 왕불유행 추출물을 유효성분으로 함유하는 피부 미백 또는 재생용 조성물을 제공한다.As one aspect for solving the above object, the present invention provides a skin whitening or regenerating composition containing an extract of King Fungus as an active ingredient.
상기 조성물은 화장료, 약학적, 건강기능식품 또는 의약외품 조성물일 수 있다.
The composition may be a cosmetic, a pharmaceutical, a health functional food or a quasi-drug composition.
왕불유행(Melandrium firmum)은 패랭이꽃과(Caryophyllacae)에 속하는 이년생 초본인 장구채(Melandrium firmum) 및 애기장구채(Melandrium apricum)의 종자로서, 활혈, 통경, 최유 등의 효능이 있어 물월경, 유즙불통, 금창출혈 등의 치료를 위해 사용되는 것으로 알려져 있다. 하지만, 피부의 미백 또는 재생과 관련된 효과는 알려진 바 없으며, 사람 피부에 대한 연구도 충분히 이루어지지 않고 있다.
Wangbul fashion (Melandrium firmum) is a biennial herbaceous jangguchae belonging to the Dianthus (Caryophyllacae) (Melandrium firmum and Melandrium apricum , and it has been known to be used for treatment of water menstruation, milk sickness , and gingival bleeding due to its efficacy, such as blood clotting, However, the effect of skin whitening or regeneration is not known, and research on human skin has not been performed sufficiently.
본 발명의 용어, "추출물"은 어떤 물질을 용매에 녹여 분리한 물질을 의미하고, 구체적으로 상기 본발명의 왕불유행의 추출처리에 의하여 얻어지는 추출액, 추출액의 희석액이나 농축액, 상기 추출액을 건조하여 얻어지는 건조물, 상기 추출액의 조정제물이나 정제물, 또는 이들의 혼합물 등의 추출액 자체 및 추출액을 이용하여 형성 가능한 모든 제형의 추출물을 포함한다.The term "extract " of the present invention means a substance obtained by dissolving a substance in a solvent, and specifically refers to a substance obtained by extracting a dilute solution or a concentrated solution of the extract, Extracts of all the formulations which can be formed using the extract itself and the extract such as the dried product, the adjusted product or the purified product of the above extract, or a mixture thereof.
상기 본 발명의 추출물은 식물의 천연, 잡종 또는 변종 식물로부터 추출될 수 있고, 식물 조직 배양물로부터도 추출될 수 있다.The extract of the present invention can be extracted from natural, hybrid, or variant plants of plants, and can also be extracted from plant tissue cultures.
상기 본 발명의 왕불유행을 추출하는 방법은 특별히 제한되지 않으며, 당해 기술 분야에서 통상적으로 사용하는 방법에 따라 추출할 수 있다. 상기 추출 방법의 비제한적인 예로는, 열수 추출법, 초음파 추출법, 여과법, 환류 추출법 등을 들 수 있으며, 이들은 단독으로 수행되거나 2 종 이상의 방법을 병용하여 수행될 수 있다.There is no particular limitation on the method for extracting the quadrillion fimbriae of the present invention, and extraction can be carried out according to a method commonly used in the art. Non-limiting examples of the extraction method include hydrothermal extraction, ultrasonic extraction, filtration, and reflux extraction. These may be performed alone or in combination with two or more methods.
상기 본 발명의 왕불유행을 추출하는데 사용되는 용매의 종류는 특별히 제한되지 않으며, 당해 기술 분야에서 공지된 임의의 용매를 사용할 수 있다. 상기 추출 용매의 비제한적인 예로는 물; 메탄올, 에탄올, 프로필알코올, 부틸알코올 등의 C1 내지 C4의 저급 알코올; 글리세린, 부틸렌글리콜, 프로필렌글리콜 등의 다가 알코올; 및 메틸아세테이트, 에틸아세테이트, 아세톤, 벤젠, 헥산, 디에틸에테르, 디클로로메탄 등의 탄화수소계 용매; 또는 이들의 혼합물을 사용할 수 있으며, 구체적으로 물, 저급알코올, 1,3-부틸렌글리콜, 에틸아세테이트를 단독으로 사용하거나 2종 이상 혼합하여 사용할 수 있다. 더욱 구체적으로 본 발명에서 왕불유행을 추출하는 용매는 물(또는 증류수)을 사용할 수 있다. 상기 용매를 사용하여 왕불유행을 1회 이상 추출하여 용매 추출물을 제조할 수 있으며, 상기 용매 추출물을 감압 증류한 후 동결건조 또는 분무 건조하여 얻은 건조 추출물을 제조할 수 있다. 본 발명의 일 실시예에서는 추출용매로 물을 사용하여 왕불유행 추출물을 제조하였다(실시예 1).There is no particular limitation on the type of solvent used for extracting the above-described quadriceps, and any solvent known in the art may be used. Non-limiting examples of the extraction solvent include water; C 1 to C 4 lower alcohols such as methanol, ethanol, propyl alcohol and butyl alcohol; Polyhydric alcohols such as glycerin, butylene glycol and propylene glycol; And hydrocarbon solvents such as methyl acetate, ethyl acetate, acetone, benzene, hexane, diethyl ether, and dichloromethane; Or a mixture thereof. Specifically, water, a lower alcohol, 1,3-butylene glycol and ethyl acetate may be used alone or in combination of two or more. More specifically, in the present invention, water (or distilled water) may be used as a solvent for extracting the quail. The solvent extract may be prepared by extracting at least one round-trip epidemic using the solvent, and the dry extract obtained by vacuum distillation or spray-drying the solvent extract may be prepared. In one embodiment of the present invention, water was used as an extraction solvent to prepare a quail extract (Example 1).
상기 본 발명에서 열수 추출한 추출물은 부유하는 고체 입자를 제거하기 위해 여과, 예를 들어 나일론 등을 이용해 입자를 걸러내거나 냉동여과법 등을 이용해 여과한 후, 그대로 사용하거나 이를 동결건조, 열풍건조, 분무건조 등을 이용해 건조시켜 사용할 수도 있다.The extract extracted with hot water in the present invention may be filtered to remove suspended solid particles, for example, by filtration using nylon or the like, or by filtration using a freeze filtration method or the like, or the extract may be used as it is or may be freeze-dried, It may be dried and used.
본 발명의 용어 "미백"은, 피부를 하얗게 하는 것을 의미하며, 멜라닌의 과도한 합성이나, 멜라닌 침착으로 인한 기미, 주근깨를 포함한 다양한 색소 침착을 완화 또는 개선하는 것을 의미한다. The term "whitening" of the present invention means to whiten skin, and means to alleviate or improve various pigmentation including stains and freckles due to excessive synthesis of melanin or melanin deposition.
본 발명의 일 실시예에서는 상기 본 발명의 왕불유행 추출물의 피부 미백 효과를 확인하기 위하여 마우스 멜라노마 세포를 사용하여 세포 수준에서의 멜라닌 합성 억제 효과를 분석하였으며, 그 결과, 종래에 사용되고 있는 미백제(알부틴)보다 월등히 우수하게 멜라닌 생성 억제능(표 1)을 나타내는 것을 확인하였다. 또한, 왕불유행 추출물을 포함하는 피부외용제 또는 에센스를 성인 남녀 20명에게 도포하여 색소 침착 개선 여부를 확인하기 위한 관능 평가를 실시하였고, 왕불유행 추출물이 기미 또는 주근깨 등의 색소 침착을 개선하는데 우수한 효과를 나타낸다는 것을 확인하였다(표 6).
In one embodiment of the present invention, the effect of inhibiting melanin synthesis at the cellular level was examined using mouse melanoma cells to confirm skin whitening effect of the quail extract of the present invention. As a result, (Table 1), which is superior to melatonin (Arbutin). In addition, sensory evaluation was carried out to examine the improvement of pigmentation by applying a skin external preparation or essence containing an extract of royal flush to 20 men and women, and it was found that the royal flush extract has excellent effect for improving pigmentation such as spots or freckles (Table 6).
본 발명의 용어 "재생"은 피부 외부 및 내부 원인에 의해 발생된 피부(세포) 손상에 대한 피부 조직의 회복 과정을 의미한다. 상기 외부 원인에 의한 손상은 자외선, 외부 오염 물질, 창상, 외상 등이 원인일 수 있으며, 상기 내부 원인에 의한 손상은 스트레스 등이 원인일 수 있다. The term "regeneration" of the present invention means a restoration process of skin tissue against skin (cell) damage caused by external and internal causes of the skin. Damage due to external causes may be caused by ultraviolet rays, external contaminants, wounds, trauma, etc. Damage due to internal causes may be caused by stress or the like.
본 발명의 일 실시예에서는 왕불유행 추출물의 피부 재생 효과를 확인하기 위하여 DPPH 방법을 통한 자유라디칼 소거능을 분석하고, 인체 섬유아세포를 배양하여 MTT 환원법으로 세포증식 촉진 활성을 분석하였다. 그 결과, 왕불유행 추출물은 자유라디칼 제거제로 사용되고 있는 아스코르브산 보다 우수한 자유라디칼 소거능을 나타내는 것을 확인하였고(표 2), 탁월한 세포증식 촉진 활성을 농도 의존적으로 나타내는 것을 확인하였다(표 3).
In one embodiment of the present invention, the free radical scavenging ability of DPPH method was analyzed to confirm the skin regeneration effect of the quail extract, and human fibroblasts were cultured and analyzed for cell proliferation promoting activity by MTT reduction method. As a result, it was confirmed that the quail extract showed excellent free radical scavenging ability as compared with ascorbic acid used as a free radical scavenger (Table 2), and showed excellent cell proliferation promoting activity in a concentration-dependent manner (Table 3).
상기 목적을 해결하기 위한 다른 하나의 양태로서, 본 발명은 왕불유행 추출물을 유효성분으로 함유하는 피부 미백 또는 재생용 화장료 조성물을 제공한다.In another aspect of the present invention, the present invention provides a cosmetic composition for skin whitening or regenerating, which contains an extract of royal flush as an active ingredient.
본 발명의 화장료 조성물은 총 조성물의 중량 대비 왕불유행 추출물을 0.0001 내지 50 중량%로 포함할 수 있으며, 구체적으로 0.01 중량% 내지 10 중량%로 포함할 수 있다. 상기 범위 내에서 우수한 피부 미백 또는 재생 효과를 나타내는 이점이 있으며, 조성물의 제형이 안정화되는 이점이 있다.The cosmetic composition of the present invention may contain 0.0001 to 50% by weight of a quintile extract, specifically 0.01 to 10% by weight, based on the weight of the total composition. There is an advantage of exhibiting excellent skin whitening or regenerating effect within the above range, and there is an advantage that the formulation of the composition is stabilized.
상기 본 발명의 화장료 조성물은 용액, 외용 연고, 크림, 폼, 영양 화장수, 유연 화장수, 팩, 유연수, 유액, 메이크업 베이스, 에센스, 비누, 액체 세정료, 입욕제, 선 스크린 크림, 선 오일, 현탁액, 유탁액, 페이스트, 겔, 로션, 파우더, 비누, 계면 활성제-함유 클렌징, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션, 패취 및 스프레이로 이루어진 군으로부터 선택되는 제형으로 제조할 수 있으나, 이에 제한되는 것은 아니다.The cosmetic composition of the present invention can be used as a cosmetic composition in the form of a solution, an ointment for external use, a cream, a foam, a nutritional lotion, a flexible lotion, a pack, a flexible water, a milky lotion, a makeup base, But are not limited to, emulsions, emulsions, pastes, gels, lotions, powders, soaps, surfactant-containing cleansing, oils, powder foundations, emulsion foundations, wax foundations, patches and sprays It is not.
상기 본 발명의 화장료 조성물은 일반 피부 화장료에 배합되는 화장품학적으로 허용 가능한 담체를 1종 이상 추가로 포함할 수 있으며, 통상의 성분으로 예를 들면 유분, 물, 계면 활성제, 보습제, 저급 알코올, 증점제, 킬레이트제, 색소, 방부제, 향료 등을 적절히 배합할 수 있으나, 이에 제한되는 것은 아니다.The cosmetic composition of the present invention may further comprise at least one cosmetically acceptable carrier to be incorporated in a general skin cosmetic composition. Examples of the cosmetic composition include ordinary ingredients such as oil, water, a surfactant, a moisturizer, a lower alcohol, , A chelating agent, a coloring agent, a preservative, a perfume, and the like may be appropriately compounded, but the present invention is not limited thereto.
상기 본 발명의 화장료 조성물에 포함되는 화장품학적으로 허용 가능한 담체는 화장료 조성물의 제형에 따라 다양하다.The cosmetically acceptable carrier contained in the cosmetic composition of the present invention varies depending on the formulations of the cosmetic composition.
본 발명의 제형이 연고, 페이스트, 크림 또는 젤인 경우에는, 담체 성분으로서 동물성 유, 식물성 유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크, 산화 아연 등이 이용될 수 있으나, 이에 제한되는 것은 아니다. 이들은 단독으로 사용되거나 2종 이상 혼합되어 사용될 수 있다.When the formulations of the present invention are ointments, pastes, creams or gels, the carrier component may be an animal oil, a vegetable oil, a wax, a paraffin, a starch, a tracer, a cellulose derivative, polyethylene glycol, silicon, bentonite, silica, talc, zinc oxide May be used, but is not limited thereto. These may be used alone or in combination of two or more.
본 발명의 제형이 파우더 또는 스프레이인 경우에는, 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록사이드, 칼슘 실케이트, 폴리아미드 파우더 등이 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로하드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진제를 포함할 수 있으나, 이에 제한되는 것은 아니다. 이들은 단독으로 사용되거나 2종 이상 혼합되어 사용될 수 있다.When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate, polyamide powder and the like may be used as a carrier component. In particular, But are not limited to, propellants such as rocaborn, propane / butane or dimethyl ether. These may be used alone or in combination of two or more.
본 발명의 제형이 용액 또는 유탁액인 경우에는, 담체 성분으로서 용매, 용해화제 또는 유탁화제 등이 이용될 수 있으며, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일 등이 이용될 수 있고, 특히, 목화씨 오일, 땅콩 오일, 옥수수 배종 오일, 올리브 오일, 피마자 오일 및 참깨 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 이용될 수 있으나, 이에 제한되는 것은 아니다. 이들은 단독으로 사용되거나 2종 이상 혼합되어 사용될 수 있다.When the formulation of the present invention is a solution or an emulsion, a solvent, a dissolving agent or an emulsifying agent may be used as a carrier component, and examples thereof include water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, Propylene glycol, 1,3-butyl glycol oil and the like can be used, and particularly fatty acid esters of cottonseed oil, peanut oil, corn oil, olive oil, castor oil and sesame oil, glycerol aliphatic ester, polyethylene glycol or sorbitan May be used, but is not limited thereto. These may be used alone or in combination of two or more.
본 발명의 제형이 현탁액인 경우에는, 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타하이드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있으나, 이에 제한되는 것은 아니다. 이들은 단독으로 사용되거나 2종 이상 혼합되어 사용될 수 있다.When the formulation of the present invention is a suspension, a carrier such as water, a liquid diluent such as ethanol or propylene glycol, a suspension such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Crystalline cellulose, aluminum metahydroxide, bentonite, agar or tracant, but are not limited thereto. These may be used alone or in combination of two or more.
본 발명의 제형이 비누인 경우에는, 담체 성분으로서 지방산의 알칼리 금속 염, 지방산 헤미에스테르 염, 지방산 단백질 히드롤리제이트, 이세티오네이트, 라놀린 유도체, 지방족 알코올, 식물성 유, 글리세롤, 당 등이 이용될 수 있으나, 이에 제한되는 것은 아니다. 이들은 단독으로 사용되거나 2종 이상 혼합되어 사용될 수 있다.When the formulation of the present invention is a soap, use is made of an alkali metal salt of a fatty acid, a fatty acid hemiester salt, a fatty acid protein hydrolizate, isethionate, a lanolin derivative, an aliphatic alcohol, a vegetable oil, glycerol, But is not limited thereto. These may be used alone or in combination of two or more.
본 발명의 제형이 계면-활성제 함유 클렌징인 경우에는, 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시테이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 오일, 라놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있으나, 이에 제한되는 것은 아니다. 이들은 단독으로 사용되거나 2종 이상 혼합되어 사용될 수 있다.
When the formulation of the present invention is an interfacial active agent-containing cleansing, it is preferable to use, as a carrier component, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyltaurate, sarcosinate, Amide ether sulfate, alkylamidobetaine, aliphatic alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, lanolin derivative, or ethoxylated glycerol fatty acid ester, but are not limited thereto. These may be used alone or in combination of two or more.
상기 목적을 해결하기 위한 또 다른 하나의 양태로서, 본 발명은 왕불유행 추출물을 유효성분으로 함유하는 피부 미백 또는 재생용 약학적 조성물을 제공한다.In another aspect of the present invention, the present invention provides a skin whitening or regenerating pharmaceutical composition containing an extract of King Fungus as an active ingredient.
본 발명의 약학적 조성물은 총 조성물의 중량 대비 왕불유행 추출물을 0.0001 내지 50 중량%로 포함할 수 있으며, 구체적으로 0.01 중량% 내지 10 중량%로 포함할 수 있다. 상기 범위 내에서 우수한 피부 미백 또는 재생 효과를 나타내는 이점이 있으며, 조성물의 제형이 안정화되는 이점이 있다.The pharmaceutical composition of the present invention may contain 0.0001 to 50% by weight, preferably 0.01 to 10% by weight, of the kingfisher fashionable extract based on the weight of the total composition. There is an advantage of exhibiting excellent skin whitening or regenerating effect within the above range, and there is an advantage that the formulation of the composition is stabilized.
상기 약학적 조성물은 정제, 환제, 산제, 과립제, 캡슐제, 현탁제, 내용액제, 유제, 시럽제, 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결 건조제 및 좌제으로 이루어진 군으로부터 선택되는 어느 하나의 제형을 가질 수 있으며, 경구 또는 비경구의 여러 가지 제형일 수 있다.The pharmaceutical composition may be any one selected from the group consisting of tablets, pills, powders, granules, capsules, suspensions, solutions, emulsions, syrups, sterilized aqueous solutions, nonaqueous solvents, suspensions, emulsions, And may be oral or parenteral formulations of various forms.
제제화할 경우에는 통상적으로 사용하는 충진제, 증량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제될 수 있다. In the case of formulation, it can be prepared by using diluents or excipients such as fillers, extenders, binders, humectants, disintegrants, surfactants and the like which are usually used.
본 발명의 제형이 경구투여를 위한 고형제제인 경우에는, 정제, 환제, 산제, 과립제, 캡슐제 등이 포함될 수 있으며, 상기 고형제제는 하나 이상의 화합물에 적어도 하나 이상의 부형제, 예를 들면 전분, 탄산칼슘, 수크로오스(sucrose) 또는 락토오스(lactose), 젤라틴 등을 섞어 조제될 수 있다. 또한, 단순한 부형제 이외에 스테아린산 마그네슘, 탈크 등과 같은 윤활제들이 사용될 수 있다. When the formulation of the present invention is a solid preparation for oral administration, it may contain tablets, pills, powders, granules, capsules and the like, and the solid preparation may contain at least one excipient such as starch, Calcium, sucrose or lactose, gelatin, and the like. In addition to simple excipients, lubricants such as magnesium stearate, talc, and the like may be used.
본 발명의 제형이 경구투여를 위한 액상제제인 경우에는, 현탁제, 내용액제, 유제, 시럽제 등이 포함될 수 있으며, 통상적으로 사용되는 단순희석제인 물, 리퀴드 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다. When the formulation of the present invention is a liquid preparation for oral administration, it may contain a suspension, a solution, an emulsion, a syrup, etc. In addition to water and liquid paraffin which are simple diluents commonly used, various excipients such as wetting agents , Sweeteners, fragrances, preservatives, and the like.
본 발명의 제형이 비경구투여를 위한 제제인 경우에는, 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결건조 제제, 좌제가 포함될 수 있다. 상기 비수성용제, 현탁용제로는 프로필렌글리콜(propylene glycol), 폴리에틸렌 글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있으며, 상기 좌제의 기제로는 위텝솔(witepsol), 마크로골, 트윈(tween) 61, 카카오지, 라우린지, 글리세로젤라틴 등이 사용될 수 있다.
When the formulation of the present invention is a preparation for parenteral administration, it may contain a sterilized aqueous solution, a non-aqueous solvent, a suspension, an emulsion, a lyophilized preparation, and a suppository. Examples of the non-aqueous and suspensions may include propylene glycol, polyethylene glycol, vegetable oils such as olive oil, injectable esters such as ethyl oleate, and the like. Examples of the suppository include witepsol, , Macrogol, tween 61, cacao paper, laurin, glycerogelatin and the like can be used.
상기 목적을 해결하기 위한 또 다른 하나의 양태로서, 왕불유행 추출물을 유효성분으로 포함하는 피부 미백 또는 재생용 건강기능식품 조성물을 제공한다.As another embodiment for solving the above object, there is provided a skin whitening or regenerating health functional food composition comprising an extract of King Fahrenheit as an active ingredient.
상기 건강기능식품 조성물은 육류, 소세지, 빵, 쵸코렛, 캔디류, 스넥류, 과자류, 피자, 라면, 껌류, 아이스크림류, 스프, 음료수, 차, 기능수, 드링크제, 알콜 음료 및 비타민 복합제 중 어느 하나의 형태일 수 있다.The health functional food composition may be in the form of any one of meat, sausage, bread, chocolate, candy, snack, confectionery, pizza, ramen, gum, ice cream, soup, beverage, tea, functional water, Lt; / RTI >
또한, 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있으며, 그 밖에 천연 과일주스 및 과일주스 음료 및 야채음료의 제조를 위한 과육을 함유할 수 있다. 이들은 단독으로 사용되거나 2종 이상 혼합되어 사용될 수 있다.It is also possible to use a variety of nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, colorants and heavies (cheese, chocolate, etc.), pectic acid and its salts, alginic acid and its salts, The composition may contain a colloidal thickener, a pH adjusting agent, a stabilizer, a preservative, a glycerin, an alcohol, a carbonating agent used in a carbonated beverage, and the like, as well as flesh for the production of natural fruit juice and fruit juice drinks and vegetable drinks . These may be used alone or in combination of two or more.
상기 건강기능식품 조성물은 식품첨가물을 추가로 포함할 수 있으며, "식품첨가물"로서의 적합 여부는 다른 규정이 없는 한 식품의약품안정처에 승인된 식품첨가물공전의 총칙 및 일반시험법 등에 따라 해당 품목에 관한 규격 및 기준에 의해 판정한다.The health functional food composition may further include food additives and the suitability of the food additives as "food additives" is to be determined by the General Regulations of the Food Additives Revision approved by the Food and Drug Administration, Shall be determined according to the relevant standards and standards.
상기 "식품첨가물공전"에 수재된 품목으로 예를 들어, 케톤류, 글리신, 구연산칼륨, 니코틴산, 계피산 등의 화학적 합성품, 감색소, 감초추출물, 결정셀롤로오스, 고랭색소, 구아검 등의 천연첨가물, L-글루타민산나트륨제제, 면류첨가알칼리제, 보존료제제, 타르색소제제 등의 혼합 제제류들을 들 수 있다.Examples of the products listed in the above-mentioned "food additives" include natural products such as ketones, chemical products such as glycine, potassium citrate, nicotinic acid and cinnamic acid, coloring matter, licorice extract, crystalline cellulosic, high- , A sodium L-glutamate preparation, a noodle-added alkaline agent, a preservative preparation, a tar coloring agent, and the like.
이때, 건강기능식품을 제조하는 과정에서 음료를 포함한 식품에 첨가되는 본 발명에 따른 추출물은 필요에 따라 그 함량을 적절히 가감할 수 있으며, 구체적으로 식품 100중량%에 0.01 내지 10 중량% 포함되도록 첨가할 수 있다.
At this time, the extract according to the present invention, which is added to foods containing beverages in the process of manufacturing a health functional food, can be appropriately added to or subtracted from the extract according to necessity. Specifically, 0.01 to 10% can do.
상기 목적을 해결하기 위한 또 다른 하나의 양태로서, 왕불유행 추출물을 유효성분으로 포함하는 피부 미백 또는 재생용 의약외품 조성물을 제공한다.In another aspect of the present invention, there is provided a whitening or regenerating quasi-product composition comprising an extract of King Fungus as an active ingredient.
상기 본 발명의 의약외품 조성물은 바디 클렌저, 소독 청결제, 세정제, 주방용 세정제, 청소용 세정제, 치약, 가글제, 물티슈, 세제, 비누, 핸드 워시, 헤어세정제, 헤어 유연제, 가습기 충진제, 마스크, 연고제 및 필터 충진제로 이루어진 군에서 선택되는 제형으로 제조할 수 있으나, 이에 제한되는 것은 아니다.
The quasi-drug composition of the present invention can be used as a body cleanser, a disinfectant cleaner, a detergent, a kitchen detergent, a cleaning detergent, a toothpaste, a gauze agent, a wet tissue, a detergent, a soap, a hand wash, a hair cleaner, a hair softener, a humidifier filler, But the present invention is not limited thereto.
상기 목적을 해결하기 위한 또 다른 하나의 양태로서, 왕불유행 추출물을 유효성분으로 포함하는 조성물을 개체에 투여하는 단계를 포함하는 피부 미백 또는 재생 방법을 제공한다.In another aspect of the present invention, there is provided a skin whitening or regenerating method comprising the step of administering to a subject a composition containing an ascorbic acid extract as an active ingredient.
본 발명의 용어, "개체"는 피부의 미백 또는 재생의 효과를 필요로하는 인간을 포함한 모든 동물을 의미하며, 본 발명의 용어, “투여”는 어떠한 적절한 방법으로 피부 미백 또는 재생을 위해 개체에 본 발명의 약학적 조성물을 도입하는 것을 의미한다. 상기 조성물의 투여 경로는 목적 조직에 도달할 수 있는 한 경구 또는 비경구의 다양한 경로를 통하여 투여될 수 있다. 구체적으로, 국소도포 등을 통한 경피투여 방식으로 투여될 수 있으나, 이에 제한되지 않는다.The term "individual" of the present invention means all animals, including humans, that require the effect of skin whitening or regeneration, and the term " administering "Quot; means introducing the pharmaceutical composition of the present invention. The administration route of the composition can be administered through various routes of oral or parenteral administration, as long as it can reach the target tissue. Specifically, they may be administered by a transdermal administration method such as, but not limited to, topical application.
본 발명의 피부 미백 또는 재생 방법은 왕불유행 추출물, 또는 이의 약학적으로 허용 가능한 염을 포함하는 약학적 조성물을 약학적 유효량으로 투여하는 것을 포함할 수 있다. 적합한 총 1일 사용량은 올바른 의학적 판단범위 내에서 처치의에 의해 결정될 수 있으며, 본 발명의 목적상, 특정 환자에 대한 구체적인 치료적 유효량은 달성하고자 하는 반응의 종류와 정도, 경우에 따라 다른 제제가 사용되는지의 여부를 비롯한 구체적 조성물, 환자의 연령, 체중, 일반 건강 상태, 성별 및 식이, 투여 시간, 투여 경로 및 조성물의 분비율, 치료기간, 구체적 조성물과 함께 사용되거나 동시 사용되는 약물을 비롯한 다양한 인자와 의약 분야에 잘 알려진 유사 인자에 따라 다르게 적용하는 것이 바람직하다.
The skin whitening or regenerating method of the present invention may comprise administering a pharmaceutical effective amount of a pharmaceutical composition comprising a quail extract, or a pharmaceutically acceptable salt thereof. Suitable total daily doses may be determined by the practitioner within the scope of sound medical judgment, and for purposes of the present invention, the specific therapeutically effective amount for a particular patient will depend upon the type and extent of the desired response, Including the age, weight, general health status, sex and diet of the patient, the time of administration, the route of administration and the fraction of the composition, the duration of treatment, the drugs used or co-used with the specific composition It is desirable to apply differently depending on the factor and similar factors well known in the medical field.
본 발명의 왕불유행 추출물을 포함하는 조성물은 피부 미백 또는 재생 효능을 갖는다. 구체적으로 본 발명의 조성물은 멜라닌 합성을 억제하고, 색소 침착을 저해하며, 자유라디칼을 소거하고, 세포증식을 촉진시키는 효능이 우수하다.The composition comprising the quail extract of the present invention has a skin whitening or regenerating effect. Specifically, the composition of the present invention is excellent in inhibiting melanin synthesis, inhibiting pigment deposition, eliminating free radicals, and promoting cell proliferation.
따라서, 천연물 유래의 물질인 본 발명의 조성물은 인체에 적용하여도 부작용을 유발하지 않아 화장료 조성물, 약학적 조성물, 건강기능식품 조성물 또는 의약외품 조성물로 유용하게 사용할 수 있다.
Therefore, the composition of the present invention, which is a material derived from a natural product, does not cause side effects even when it is applied to human body, and thus can be effectively used as a cosmetic composition, a pharmaceutical composition, a health functional food composition or a quasi-drug composition.
이하, 실시예를 통하여 본 발명의 구성 및 효과를 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 예시하기 위한 것일 뿐 본 발명의 범위가 이들 실시예에 의해 제한되는 것은 아니다.
Hereinafter, the constitution and effects of the present invention will be described in more detail through examples. These embodiments are only for illustrating the present invention, and the scope of the present invention is not limited by these embodiments.
실시예Example 1: One: 왕불유행A fad 추출물의 제조 Preparation of extract
구입한 왕불유행 50g에 증류수 1L를 넣고 4시간 동안 끓인 다음 여과하고, 이를 건조하여 파우더 8.5g을 얻었다.
1 L of distilled water was added to 50 g of the purchased royal flue, which was boiled for 4 hours, filtered, and dried to obtain 8.5 g of a powder.
실시예Example 2: 멜라닌 생성 억제 시험 2: Melanin production inhibition test
세포 수준에서 왕불유행 추출물의 미백 효과를 확인하기 위해, 상기 획득한 왕불유행 추출물을 마우스의 멜라노마 세포(B-16) 배양액에 첨가하여 멜라닌 생성 억제 효과를 확인하였다.In order to confirm the whitening effect of the royal flush extract at the cell level, the obtained royal flush extract was added to the melanoma cell (B-16) culture solution of the mouse to confirm the melanin production inhibitory effect.
최종농도 0.1 ㎍/㎖, 1 ㎍/㎖ 또는 10 ㎍/㎖의 왕불유행 추출물을 B-16 멜라노마 세포의 배양액에 각각 첨가하여 3일간 배양하였다. 이후, 세포들을 트립신(trypsin) 처리하여 배양용기로부터 떼어내 원심분리하고, 멜라닌을 추출하였다. 추출한 멜라닌에 수산화나트륨 용액(1N) 1 ㎖을 가한 후, 10분 동안 끓여 멜라닌을 용해하였고, 분광광도계를 이용하여 400 nm에서 용해물의 흡광도를 측정하였다. 생성된 멜라닌 양은 단위 세포수(106 세포) 당 흡광도로 나타내는 방법으로 측정하였다. 이때, 대조군으로는, 왕불유행 추출물을 첨가하지 않은 음성대조군과 음성대조군에 200 mg/㎖의 알부틴(arbutin)을 첨가한 양성대조군, 두 가지를 사용하였다. The final concentration of 0.1 ㎍ / ㎖, 1 ㎍ / ㎖ or 10 ㎍ / ㎖ of the raffinate extract was added to the culture medium of B-16 melanoma cells and cultured for 3 days. The cells were then trypsinized, detached from the culture vessel, centrifuged, and extracted with melanin. One milliliter of sodium hydroxide solution (1N) was added to the extracted melanin. Melanin was boiled for 10 minutes, and the absorbance of the melt was measured at 400 nm using a spectrophotometer. The amount of melanin produced was measured by the method of measuring absorbance per unit cell number (10 6 cells). At this time, two control groups were used: a negative control group without the royal flush extract and a positive control group supplemented with 200 mg / ml of arbutin for the negative control group.
왕불유행 추출물을 첨가한 세포의 멜라닌 생성량은 음성대조군에 대한 저해율(%)로 계산하였고, 세 번의 실험을 반복하여 얻은 결과를 하기 표 1에 정리하였다.The amount of melanin production in the cells supplemented with the quail extract was calculated as the inhibition rate (%) for the negative control, and the results obtained by repeating the three experiments are summarized in Table 1 below.
(음성대조군+알부틴(200 mg/㎖))Positive control group
(Negative control + arbutin (200 mg / ml))
상기 표 1의 결과에서 보듯이, 왕불유행 추출물을 처리한 경우, 왕불유행 추출물을 처리하지 않은 음성대조군과 비교하여 최소 48% 이상의 멜라닌 생성 저해 효과를 발휘하였으며, 왕불유행 추출물은 일반적으로 미백 물질이라고 알려진 알부틴을 적용한 양성대조군보다 더 적은 농도로 월등히 우수한 멜라닌 생성 억제 효과가 있음을 확인하였다.
As can be seen from the results of Table 1 above, when treated with the royal flush extract, at least 48% of the melanin formation inhibitory effect was exhibited as compared with the negative control without the royal flush extract, and the royal flush extract was generally a whitening substance It was confirmed that melanin synthesis inhibition effect was significantly superior to that of known arbutin-based control group.
실시예Example 3: 피부 재생 효과 분석 3: Analysis of skin regeneration effect
실시예Example 3-1: 3-1: 자유라디칼Free radical 소거능Scatters 분석 analysis
피부 손상(피부 세포 재생 저하)을 유발하는 활성산소(자유라디칼) 생성에 대해 왕불유행 추출물이 미치는 영향을 확인하기 위하여, 라디칼 상태로 존재시 517 nm에서 최대 흡광을 보이며, 라디칼이 소거되면 흡광성을 잃는 특성이 있는 비교적 안정한 자유라디칼인 1,1-디페닐-2-피크릴히드라질(DPPH) 방법으로 자유라디칼 소거능을 측정하였다. DPPH(Sigma사에서 구입)는 0.15 mM의 농도로 메틸 알코올에 녹여 사용하였다. In order to examine the effect of the quail extract on the production of free radicals which cause skin damage (skin cell regeneration), the maximum absorption at 517 nm in the presence of radicals is observed, and when the radicals are eliminated, Free radical scavenging activity was measured by the relatively stable free radical 1,1-diphenyl-2-picryl hydrazine (DPPH) method, which has the property of losing its activity. DPPH (purchased from Sigma) was dissolved in methyl alcohol at a concentration of 0.15 mM.
먼저, 왕불유행 추출물을 96-웰 플레이트의 각 웰에 100 ㎕씩 넣고, DPPH 용액 100 ㎕를 각각 첨가한 후, 상온에서 30분간 방치하였다. 이후, Micro plate reader(BiotTek EL-340)를 이용하여 517 nm에서 흡광도를 측정하였다. 이때, 대조군으로는 왕불유행 추출물을 첨가하지 않은 상태에서, 자유라디칼 제거제로 알려진 아스코르브산을 첨가한 대조군 1과 자유라디칼 소거능을 갖는 메틸 알코올을 첨가한 대조군 2, 두 가지를 사용하였다.First, 100 μl of each of the wells of the 96-well plate was added with 100 μl of the DPPH solution, and then left at room temperature for 30 minutes. The absorbance was then measured at 517 nm using a Micro plate reader (BiotTek EL-340). At this time, control group 1, in which ascorbic acid, which is known as a free radical scavenger, was added and control group 2 in which methyl alcohol having free radical scavenging ability was added in the absence of the royal flush extract.
결과는, 시료를 처리한 시험군의 흡광도가 대조군의 흡광도에 대해 절반 수준이 될 때의 왕불유행 추출물의 농도인 IC50(Inhibitory Concentration 50)으로 표시하였고, 하기 표 2에 정리하였다. The results are shown in Table 2 as IC 50 (Inhibitory Concentration 50), which is the concentration of the quail extract when the absorbance of the test group treated with the sample is half the absorbance of the control group.
(아스코르브산)Control 1
(Ascorbic acid)
(메틸 알코올) Control group 2
(Methyl alcohol)
상기 표 2의 결과에서 보듯이, 왕불유행 추출물을 처리한 경우, 아스코르브산을 처리한 대조군 1보다 현저히 우수한 자유라디칼 소거능을 보였으며, 또한, 메틸 알코올을 처리한 대조군 2와 비교하여도 강력한 자유라디칼을 소거 효과를 보인다는 것을 확인하였다.
As can be seen from the results of Table 2 above, the treatment with the quail extract showed a remarkably superior free radical scavenging ability compared with the control group 1 treated with ascorbic acid. In addition, compared with the control group 2 treated with methyl alcohol, Which shows the effect of erasing.
실시예Example 3-2: 세포증식 3-2: Cell proliferation 활성능Bow performance 측정 Measure
피부세포 증식 활성화에 대하여 왕불유행 추출물이 미치는 영향을 확인하기 위해, 사람의 섬유아세포를 사용하여 세포증식 활성능을 측정하였다. In order to confirm the effect of the quail extract on the activation of skin cell proliferation, the cell proliferation activity of human fibroblast was measured.
다양한 농도(0.01 ㎍/㎖, 0.1 ㎍/㎖, 1 ㎍/㎖, 10 ㎍/㎖)의 왕불유행 추출물을 배양액에 첨가한 후, 사람의 섬유아세포를 배양하여 MTT 환원법을 수행하고, 포르마잔(formazan) 생성물을 이소프로필 알코올로 추출하여, 570 nm에서 흡광도를 측정함으로써 세포증식 활성능을 상대비교하였다. 이때, 대조군으로는, FBS(fetal bovine serum) 및 왕불유행 추출물을 넣지 않은 배양액를 사용한 음성대조군, 10% FBS를 넣은 배양액를 사용한 양성대조군, 두 가지를 사용하였다. After adding the royal flush extract of various concentrations (0.01 ㎍ / ㎖, 0.1 ㎍ / ㎖, 1 ㎍ / ㎖, 10 ㎍ / ㎖) to the culture medium, human fibroblasts were cultured to perform MTT reduction, formazan were extracted with isopropyl alcohol and the absorbance at 570 nm was measured. At this time, two control groups were used: a negative control using FBS (fetal bovine serum) and a culture solution without the quail extract, and a positive control using culture with 10% FBS.
5회 반복 시험하여 측정한 결과를 하기 수학식 1을 이용하여 수치로 계산하였고, 하기 표 3에 정리하였다. The result of the measurement was repeated five times, and the results were calculated by numerical values using the following Equation 1, and are summarized in Table 3 below.
[수학식 1][Equation 1]
세포증식능Cell proliferation ability (%) = 각 (%) = Angle 시료군에서의In the sample group 흡광도/대조군에서의 흡광도 Absorbance / absorbance in the control group
왕불유행 추출물
Kingfisher fashionable extract
상기 표 3의 결과에서 보듯이, 왕불유행 추출물을 처리한 경우, 최소 실험 처리 농도(0.01 ㎍/㎖)에서 113.1%의 세포증식 활성능을 보였으며, 이는 아무것도 처리하지 않은 대조군의 세포증식 활성능(100%)에 비하여 증가한 것임을 확인하였다. As shown in the results of Table 3 above, the cell proliferation activity was 113.1% at the minimum experimental treatment concentration (0.01 μg / ml) in the case of treatment with the quail extract, (100%) compared to the control group.
따라서, 본 발명의 왕불유행 추출물은 세포증식을 통한 세포활성 효과가 탁월하여 손상된 피부의 재생을 위한 화장료 조성물, 예컨대 피부 외용제뿐만 아니라 약학적 조성물 또는 건강기능식품 조성물로도 유용하게 사용될 수 있음을 확인하였다.
Accordingly, it has been confirmed that the extract of the present invention can be effectively used as a cosmetic composition for regenerating damaged skin, for example, a skin external preparation, a pharmaceutical composition or a health functional food composition, because of its excellent cell activity effect through cell proliferation Respectively.
제조예Manufacturing example 1 및 1 and 비교예Comparative Example 1: 피부 외용제의 제조 1: Preparation of external preparation for skin
하기 표 4의 조성과 같이, 왕불유행 추출물을 유효성분으로 포함하는 피부 미백 또는 재생용 피부 외용제를 통상의 방법에 따라 제조하였다(제조예 1). 또한, 유효성분을 제외한 나머지 성분으로 제조한 피부 외용제를 비교예 1의 조성으로 제조하였다.Skin whitening or regenerating dermatological external preparations containing, as an active ingredient, a quadriceps fashion extract was prepared according to a conventional method (Production Example 1). In addition, the external preparation for skin prepared from the components other than the active ingredient was prepared with the composition of Comparative Example 1.
제조예Manufacturing example 2 및 2 and 비교예Comparative Example 2: 에센스의 제조 2: Preparation of essence
하기 표 5의 조성과 같이, 왕불유행 추출물을 유효성분으로 포함하는 피부 미백 또는 재생용 에센스를 통상의 방법에 따라 제조하였다(제조예 2). 또한, 유효성분을 제외한 나머지 성분으로 제조한 에센스를 비교예 2의 조성으로 제조하였다.Skin whitening or regenerating essence containing an extract of King Fungus as an active ingredient was prepared according to a conventional method (Production Example 2). In addition, an essence prepared from the other ingredients except for the active ingredient was prepared with the composition of Comparative Example 2.
실시예Example 5: 관능실험 5: Sensory experiment
실시예Example 5-1: 색소침착 저해 효과 분석 5-1: Pigmentation inhibition effect analysis
피부 색소침착 저해에 대한 상기 제조예 1 및 2의 조성에 따라 제조한 피부 외용제 및 에센스의 효과를 확인하기 위하여, 비교 관능실험을 수행하였다. In order to confirm the effects of the external preparation for skin and the essence produced according to the compositions of Preparation Examples 1 and 2 against skin pigmentation inhibition, comparative sensory tests were conducted.
건강한 남·여 20명을 선정하여 양팔의 하박부에 직경 7 ㎜ 구멍이 6개씩 두 줄로 파인 알루미늄 호일을 붙이고, 팔에서 10 ㎝ 떨어진 거리에서 ORIEL solar simulator 1000W를 사용하여 60 mJ/㎠의 광량을 조사하였다. 조사 전에 70% 에탄올 수용액으로 조사 부위를 세척하고 실험을 진행하였다. 조사 3일 전부터 조사 후 3주째까지 1일 2회씩 상기 제조예 1 및 2, 또한 비교예 1 및 2에 따라 제조한 피부 외용제 및 에센스를 각 한 줄에 도포하였다. 색소침착도를 육안으로 판정하고, 상기 비교예에 대하여 상기 제조예가 색소침착을 억제한 정도를 효과 있음, 또는 효과 없음의 2 단계로 평가하였으며, 결과를 하기 표 6에 나타내었다. Twenty healthy men and women were selected, and aluminum foil with 6 rows of 7 ㎜ holes was attached to the lower part of both arms, and light intensity of 60 mJ / ㎠ was measured using ORIEL solar simulator 1000W at a distance of 10 ㎝ from the arm Respectively. Before irradiation, the irradiated area was washed with 70% ethanol aqueous solution and the experiment was conducted. The external preparation for skin and the essence prepared in accordance with Preparation Examples 1 and 2 and Comparative Examples 1 and 2 were applied to each row three days before irradiation to three weeks after irradiation, twice per day. The degree of discoloration was visually determined, and the degree of suppression of pigmentation by the above-mentioned production example was evaluated by two steps of effectiveness or no effect. The results are shown in Table 6 below.
상기 표 6의 결과에서 보듯이, 상기 본 발명의 왕불유행 추출물을 함유하는 피부 외용제 및 에센스가 왕불유행 추출물을 함유하지 않은 비교예의 피부외용제 및 에센스에 비하여 미백 효과를 나타내었으며, 피부 내에서 어떠한 부작용도 나타내지 않는다는 것을 확인하였다. As shown in the results of Table 6, the external preparation for skin and essence containing the extract of the present invention showed a whitening effect in comparison with the external preparation for skin and essence of Comparative Examples which did not contain the extract of royal flush, .
따라서, 본 발명의 왕불유행 추출물 또는 이를 포함하는 조성물은 기미나 주근깨의 개선 또는 피부 미백을 위한 피부 외용제, 또는 화장료로 유용하게 사용할 수 있음을 확인하였고, 피부에 대하여 안전하다는 것을 추가로 확인하였다.
Accordingly, it has been confirmed that the extract of the present invention or the composition containing the same can be effectively used as a skin external preparation or cosmetic for improvement of spots or freckles or skin whitening, and further confirmed to be safe for skin.
이상의 설명으로부터, 본 발명이 속하는 기술분야의 당업자는 본 발명이 그 기술적 사상이나 필수적 특징을 변경하지 않고서 다른 구체적인 형태로 실시될 수 있다는 것을 이해할 수 있을 것이다. 이와 관련하여, 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적인 것이 아닌 것으로서 이해해야만 한다. 본 발명의 범위는 상기 상세한 설명보다는 후술하는 특허 청구범위의 의미 및 범위 그리고 그 등가 개념으로부터 도출되는 모든 변경 또는 변형된 형태가 본 발명의 범위에 포함되는 것으로 해석되어야 한다.From the above description, it will be understood by those skilled in the art that the present invention may be embodied in other specific forms without departing from the spirit or essential characteristics thereof. In this regard, it should be understood that the above-described embodiments are to be considered in all respects as illustrative and not restrictive. The scope of the present invention should be construed as being included in the scope of the present invention without departing from the scope of the present invention as defined by the appended claims.
Claims (10)
Melandrium firmum ) as an active ingredient.
The composition of claim 1, wherein the composition is a cosmetic, pharmaceutical, health functional food or quasi-drug composition.
2. The composition of claim 1, wherein said composition comprises from 0.01% to 10% by weight of a flavor-rich extract of the total composition.
The composition of claim 1, wherein the skin whitening is due to melanin synthesis inhibitory activity.
The composition of claim 1, wherein the skin regeneration is by free radical scavenging ability.
The composition according to claim 1, wherein the skin regeneration is by cell proliferation promoting activity.
The cosmetic composition according to claim 2, wherein the cosmetic composition is at least one selected from the group consisting of a solution, an ointment for external use, a cream, a foam, a nutritional lotion, a flexible lotion, a pack, a flexible water, a latex, a makeup base, , A formulation selected from the group consisting of suspensions, emulsions, pastes, gels, lotions, powders, soaps, surfactant-containing cleansing, oils, powder foundations, emulsion foundations, wax foundations, patches and sprays Composition.
The health functional food composition according to claim 2, wherein the health functional food composition is at least one selected from the group consisting of meat, sausage, bread, chocolates, candies, snacks, confectionery, pizza, ramen, gum, ice cream, soup, ≪ / RTI > or a combination thereof.
The composition according to claim 2, wherein the quasi-drug composition has a form selected from the group consisting of a body cleanser, a wet tissue, a soap, a hand wash, a humidifier filler, and an ointment agent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150082862A KR102379698B1 (en) | 2015-06-11 | 2015-06-11 | A composition for skin whitening or regeneration comprising Melandrium firmum extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150082862A KR102379698B1 (en) | 2015-06-11 | 2015-06-11 | A composition for skin whitening or regeneration comprising Melandrium firmum extract |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20160147136A true KR20160147136A (en) | 2016-12-22 |
KR102379698B1 KR102379698B1 (en) | 2022-03-29 |
Family
ID=57723471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150082862A KR102379698B1 (en) | 2015-06-11 | 2015-06-11 | A composition for skin whitening or regeneration comprising Melandrium firmum extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102379698B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180079139A (en) * | 2016-12-31 | 2018-07-10 | (주)셀바이오 | Cosmetic composition generating carbon dioxide with excellent shelf life in in hign temperature environment |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20240059260A (en) * | 2022-10-27 | 2024-05-07 | 경희대학교 산학협력단 | Composition for preventing or treating radiation-resistant head and neck cancer comprising Melandrium firmum Rohrbach extract as an active ingredient |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150024605A (en) * | 2013-08-27 | 2015-03-09 | 영남대학교 산학협력단 | Composition for inhibiting cellular senescence comprising extracts of Melandrium firmum Rohrbach or bornesitol isolated from the same |
-
2015
- 2015-06-11 KR KR1020150082862A patent/KR102379698B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150024605A (en) * | 2013-08-27 | 2015-03-09 | 영남대학교 산학협력단 | Composition for inhibiting cellular senescence comprising extracts of Melandrium firmum Rohrbach or bornesitol isolated from the same |
Non-Patent Citations (1)
Title |
---|
Journal of Meridian Acupuncture and Acupoints, Vol. 26, No. 4, 107~118 pages, published in December 2009 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180079139A (en) * | 2016-12-31 | 2018-07-10 | (주)셀바이오 | Cosmetic composition generating carbon dioxide with excellent shelf life in in hign temperature environment |
Also Published As
Publication number | Publication date |
---|---|
KR102379698B1 (en) | 2022-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101971837B1 (en) | Cosmetic composition for improving skin whitening and wrinkle comprising adventitious root extract of Centella asiatica as effective component | |
KR101887956B1 (en) | Composition for skin lightening comprising extract of Ecklonia cava treated by enzyme | |
KR20180004367A (en) | Cosmetic composition with the extract of Aurea Helianthus for skin-whitening | |
KR101957847B1 (en) | Composition for skin whitening comprising kadsura coccinea extract | |
KR102022622B1 (en) | Composition for improving skin conditions comprising panax ginseng sprout extract or fraction thereof and method for improving skin conditions using the same | |
KR20150050310A (en) | Composition for improving skin conditions comprising artemisiae annuae herba, neem leaf, centella asiatica and green tea extract or fraction thereof and method for improving skin conditions using the same | |
KR102379698B1 (en) | A composition for skin whitening or regeneration comprising Melandrium firmum extract | |
KR102283040B1 (en) | Cosmetic or pharmaceutical composition for skin whitening, elasticity, anti-wrinkle, or skin moisturizing comprising atractylenolide I | |
KR101854766B1 (en) | Skin whitening complex containing trihydroxyisoflavone and glycyrrhiza uralensis extracts | |
KR102431819B1 (en) | Cosmetic composition comprising fermented extract of Citrus grandis Osbeck and Dendropanax morbifera | |
KR102629000B1 (en) | Composition for skin improvement containing Salvianolic acid C | |
KR20210134589A (en) | Composition for improving skin comprising an extract of Pueraria thomsonii or a compound derived therefrom | |
KR20100042086A (en) | Composition for whitening containing extract of cortex cinnamomi cassiae | |
KR102503190B1 (en) | Composition for improving skin conditions comprising Ajugol | |
KR102293928B1 (en) | Cosmetic or pharmaceutical composition for skin whitening, elasticity, anti-wrinkle, or skin moisturizing comprising Wogonoside or a pharmaceutically acceptable salt thereof | |
KR102272742B1 (en) | Whitening composition containing Daphne odora | |
KR102348148B1 (en) | Cosmetic or pharmaceutical composition for melanism, elasticity, anti-wrinkle, or skin moisturizing comprising dihydroartemisinin | |
KR102356144B1 (en) | Cosmetic composition and health functional food for skin whitening and anti-wrinkle | |
KR20180072381A (en) | Composition for improving skin condition comprising extract of Pisum sativum var. arvense (L.) Poir. | |
KR102431820B1 (en) | Cosmetic composition comprising extract of Citrus grandis Osbeck and Dendropanax morbifera | |
KR20190033871A (en) | Complex cosmetic composition for improving skin-aging | |
KR101079713B1 (en) | Composition for Whitening Containing Extract of Talinum crassifolium as an active ingredient | |
KR102662256B1 (en) | Composition for skin improvement containing Syringaresnol-4-O-β-D-apiofuranosy | |
KR102700608B1 (en) | Composition for skin improvement containing rehmapicroside | |
KR102665307B1 (en) | Composition for skin improvement containing acetylcimigenol arabinoside |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |